Morningstar Investor users sign in here.

Company Profile

  • Business description

    Listed on the Hong Kong Stock Exchange in 2000, Sino Biopharmaceutical is one of the largest Chinese drugmakers. It started with generic drug manufacturing. Since 2018, Sino Biopharm has been actively pivoting into an innovative drugmaker after the Chinese government launched its volume-based procurement policy for the healthcare industry. As of 2023, 37.8% of the firm's total revenue comes from five innovative drugs and five biosimilar drugs. Sino Biopharm’s biggest revenue segment is oncology medicines, accounting for 33.6% of total revenue, followed by hepatitis, surgery/analgesia, respiratory, and cardio-cerebral vascular therapeutic areas.

  • Contact

    1 Harbour Road
    Unit 09, 41st Floor, Office Tower, Room 4109
    Convention Plaza
    Wanchai
    Hong Kong
    HKG

    T: +852 28029886

    https://www.sinobiopharm.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2024

    Employees

    25,806

Stocks News & Analysis

video

Top opportunities in the Aussie tech and AI space

Morningstar's Michael Malseed interviews First Sentier's Dawn Kanelleas and Maple-Brown Abbott's Phil Hudak. 
stocks

3 wide moat shares at five-star prices

Our analysts think these companies enjoy durable competitive advantages with the potential to last for at least 20 years. The shares also look cheap.
stocks

Undervalued ASX share bolsters acquisition firepower

We recommend shareholders participate in equity raise.

Markets

Index
Last price
Change
% Change
All Ordinaries 8,015.80 72.20 0.91%
CAC 40 7,616.90 45.33 0.60%
DAX 40 18,153.78 85.57 0.47%
Dow JONES (US) 38,778.10 188.94 0.49%
FTSE 100 8,178.26 36.11 0.44%
HKSE 17,915.55 20.57 -0.11%
NASDAQ 17,857.02 168.14 0.95%
Nikkei 225 38,482.11 379.67 1.00%
NZX 50 Index 11,767.40 68.89 0.59%
S&P 500 5,473.23 41.63 0.77%
S&P/ASX 200 7,778.10 77.80 1.01%
SSE Composite Index 3,030.25 14.36 0.48%

Market Movers

Name
Last price
Change
% Change
Fortescue Ltd FMG 21.79 1.19 -5.18%
Melbana Energy Ltd MAY 0.05 0.02 -31.82%
Pilbara Minerals Ltd PLS 3.26 0.12 3.82%
Core Lithium Ltd CXO 0.09 0.00 3.45%
Sayona Mining Ltd SYA 0.04 0.00 0.00%
Telstra Group Ltd TLS 3.60 0.05 1.41%
Beach Energy Ltd BPT 1.53 0.04 -2.24%
Imugene Ltd IMU 0.06 0.00 -3.45%
Red 5 Ltd RED 0.45 0.01 -1.10%
South32 Ltd S32 3.64 0.02 0.55%